Drugs / OPC-214870
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04241965 | Feb 2020 → Oct 2021 | epilepsy | Otsuka Pharmaceutical Development & Commercialization, Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | OPC-214870 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04241965 ↗ |
| Route | Oral | “Single Oral Tablet Doses” NCT04241965 ↗ |